| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-448-30 | 59651-448 | HUMAN PRESCRIPTION DRUG | DEFERASIROX | DEFERASIROX | GRANULE | ORAL | 20250908 | N/A | ANDA | ANDA215137 | Aurobindo Pharma Limited | DEFERASIROX | 180 mg/1 | 30 PACKET in 1 CARTON (59651-448-30) / 1 GRANULE in 1 PACKET (59651-448-77) |
| 59651-449-30 | 59651-449 | HUMAN PRESCRIPTION DRUG | DEFERASIROX | DEFERASIROX | GRANULE | ORAL | 20250908 | N/A | ANDA | ANDA215137 | Aurobindo Pharma Limited | DEFERASIROX | 360 mg/1 | 30 PACKET in 1 CARTON (59651-449-30) / 1 GRANULE in 1 PACKET (59651-449-54) |
| 59651-447-30 | 59651-447 | HUMAN PRESCRIPTION DRUG | DEFERASIROX | DEFERASIROX | GRANULE | ORAL | 20250908 | N/A | ANDA | ANDA215137 | Aurobindo Pharma Limited | DEFERASIROX | 90 mg/1 | 30 PACKET in 1 CARTON (59651-447-30) / 1 GRANULE in 1 PACKET (59651-447-38) |